US Patent

US10675325 — Stable formulations of linaclotide

Formulation · Assigned to Forest Laboratories Holdings ULC · Expires 2031-08-11 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects stable pharmaceutical compositions of linaclotide or its pharmaceutically acceptable salts.

USPTO Abstract

The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.

Drugs covered by this patent

Patent Metadata

Patent number
US10675325
Jurisdiction
US
Classification
Formulation
Expires
2031-08-11
Drug substance claim
No
Drug product claim
Yes
Assignee
Forest Laboratories Holdings ULC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.